Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levosalbutamol cream - Cipher Pharmaceuticals

Drug Profile

Levosalbutamol cream - Cipher Pharmaceuticals

Alternative Names: R-salbutamol cream - Astion Pharma; ASF-1096

Latest Information Update: 24 Jun 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Astion Pharma A/S
  • Developer Astion Pharma A/S; Edesa Biotech
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Phenethylamines; Skin disorder therapies; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cutaneous lupus erythematosus
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Cutaneous lupus erythematosus; Discoid lupus erythematosus
  • Preclinical Gastrointestinal disorders

Most Recent Events

  • 20 Jun 2016 Preclinical trials in Gastrointestinal disorders in Canada (unspecified route)
  • 20 Jun 2016 Levosalbutamol licensed to Edesa Biotech worldwide for the treatment of Anorectal disorders
  • 17 Apr 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top